Overview
The 20-Week Breakout scan generated 136 total signals on 2026-08-27, split between 98 bullish (dollar_20_wk + pct_20_wk) and 38 bearish (dollar_d20_wk + pct_d20_wk) readings. The resulting 72.1% bullish ratio falls into the “mostly bullish” zone, signaling active institutional accumulation and strong upside momentum breadth across the tape.
However, the SA Regime remains Cautious, with breadth at just 52.6% of stocks above SMA-40 and sentiment reading Bullish/Neutral — a mismatch versus the strong breakout ratio. Leading sectors by ATR% are Health Care (3.1%), Communication Services (2.5%), and Energy (1.9%), while Industrials, Real Estate, and Utilities show outright contraction. This favors selective, sector-aligned setups over broad-based aggression.
Quality Score: 3/5. The bullish/bearish ratio and signal count support conviction, but the Cautious regime caps enthusiasm — only setups aligned with leading sectors (Health Care, Communication Services) and clean ATR multiples earn top-tier scores today.
Top 5 Bullish Picks
MCK ($891.28) — Medical / Medical-Distribution
McKesson posted a decisive dollar breakout with a 2.62x ATR multiple on 3.1% ADR, aligning with the top-performing Health Care sector. Volume was below average (0.9x rel volume), suggesting the move is price-driven rather than a volume spike, but the stock trades only 10.8% off its 52-week high with a strong 31.6% cushion above its 52-week low.
| Level | Price |
|---|---|
| Stop (Price – 1x ATR) | $866.13 |
| Entry | $891.28 |
| Target 1 (+2x ATR) | $941.58 |
| Target 2 (+3x ATR) | $966.73 |
Institutional Interest: Fund count data unavailable (0 reported); bucket classification funds_1000 indicates broad institutional coverage universe.
ARGX ($1058.90) — Medical / Profitable Biotech
argenx is trading at its 52-week high with a 5.52x ATR multiple, one of the strongest readings in today’s scan. Rel volume of 1.0 confirms participation matches average turnover, and the 60.0% distance above the 52-week low underscores a durable uptrend in a profitable biotech name — a rare combination in this sector.
| Level | Price |
|---|---|
| Stop (Price – 1x ATR) | $1,026.61 |
| Entry | $1,058.90 |
| Target 1 (+2x ATR) | $1,123.48 |
| Target 2 (+3x ATR) | $1,155.77 |
Institutional Interest: Fund count 0 reported/undefined; classified under all_unique_bucket_1_stocks, reflecting concentrated institutional ownership tier.
INBX ($123.93) — Medical / Development Biotech
Inhibrx delivered a 5.19x ATR multiple breakout on elevated 7.7% ADR, with rel volume matching its average (1.0x). Despite sitting 20.2% off its 52-week high, the stock is up a remarkable 390.4% versus its 52-week low, reflecting a powerful multi-month re-rating in development-stage biotech.
| Level | Price |
|---|---|
| Stop (Price – 1x ATR) | $116.19 |
| Entry | $123.93 |
| Target 1 (+2x ATR) | $139.41 |
| Target 2 (+3x ATR) | $147.15 |
Institutional Interest: No fund count reported; no bucket assignment (N/A), suggesting this is a smaller, less institutionally tracked name — appropriate for tighter position sizing.
MSFT ($504.91) — Software / Comp Sftwr-Enterprise
Microsoft posted an outsized 7.56x ATR multiple, the strongest in today’s bullish list, despite modest 2.2% ADR — indicative of a large, sustained dollar move on institutional-scale volume (27.4M shares). The stock remains 44.6% above its 52-week low with room below its 52-week high (-8.8%), a constructive setup for a mega-cap leader.
| Level | Price |
|---|---|
| Stop (Price – 1x ATR) | $492.90 |
| Entry | $504.91 |
| Target 1 (+2x ATR) | $528.93 |
| Target 2 (+3x ATR) | $540.94 |
Institutional Interest: Fund count undefined in feed; bucket funds_1000 confirms this name sits within the broadest institutional-tracked universe.
LITE ($956.14) — Telecom / Telecom-Equipment
Lumentum’s breakout carries a 2.18x ATR multiple on a high 9.2% ADR, aligning with strength in the Communication Services sector. The stock is up an extraordinary 672.5% from its 52-week low, though the elevated 49.6% LOD Risk ATR% signals wider intraday swings — position sizing should account for volatility.
| Level | Price |
|---|---|
| Stop (Price – 1x ATR) | $879.23 |
| Entry | $956.14 |
| Target 1 (+2x ATR) | $1,109.96 |
| Target 2 (+3x ATR) | $1,186.87 |
Institutional Interest: Fund count undefined; bucket all_unique_bucket_1_stocks indicates concentrated institutional holding tier consistent with high-growth telecom equipment names.
Bearish Alerts
The 38 bearish signals are broadly distributed rather than sector-concentrated. MUSA (-2.81x ATR, Retail-Super/Mini Mkts) and RL (-2.71x ATR, Apparel) show the deepest breakdowns, both with elevated rel volume (1.3x and 1.2x) confirming distribution. SNDK (-0.84x ATR) and SFBS (-0.45x ATR) show milder weakness. Notably, LLY (-0.26x ATR) is a bearish outlier within the otherwise strongest sector (Health Care), a divergence worth monitoring against MCK, ARGX, and INBX strength.
Sector Theme
Bullish momentum is clearly concentrated in Health Care (MCK, ARGX, INBX) and spilling into Communication Services-adjacent Telecom (LITE) and Software (MSFT), directly mirroring the leading ATR% sectors identified in the regime data. Bearish signals lack a unifying sector theme, appearing in Retail, Consumer, Banks, Computer, and one Medical name (LLY) — suggesting idiosyncratic weakness rather than systemic sector rotation out of any single group.
Institutional Summary
Fund count data was uniformly unreported (0/undefined) across all featured tickers today, limiting direct accumulation-tracking. As a proxy, bucket classifications point to MCK and MSFT sitting in the broad funds_1000 tier, while ARGX and LITE fall into the more concentrated all_unique_bucket_1_stocks tier — both indicative of active institutional coverage. INBX carries no bucket assignment, consistent with a smaller-cap, earlier-stage institutional footprint. Investors should monitor next-cycle fund flow updates to confirm accumulation behind today’s price breakouts.